Focus on the p53 gene and cancer: Advances in TP53 mutation research

Human Mutation

Volumn 21, Issue 3, 2003, Pages 173-175

  Soussi, Thierry ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PROTEIN P53; PROTEIN P63; PROTEIN P73;

CANCER; EDITORIAL; ENVIRONMENTAL EXPOSURE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN FAMILY; SMOKING; TUMOR MODEL; TUMOR SUPPRESSOR GENE;

HUMANS; MUTATION; NEOPLASMS; RESEARCH; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037217669     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10191     Document Type: Editorial

References (31)

1. Baker SJ, Fearon ER, Nigro J, Hamilton S, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, Whyte R, Vogelstein B. 1989. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221.
2. Bénard J, Douc-Rasy S, Ahomadegbe J-C. 2003. The TP53 family members and human cancers. Hum Mutat 21: 182-191.
3. Béroud C, Soussi T 2003. The UMD-p53 database: new mutations and analysis tools. Hum Mutat 21:176-181.
4. Blons H, Laurent-Puig P. 2003. TP53 and head and neck neoplasms. Hum Mutat 21:252-257.
5. Børresen-Dale A-L. 2003. TP53 and breast cancer. Hum Mutat 21:292-300.
6. Caron de Fromentel C, Soussi T 1992. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chrom Cancer 4:1-15.
7. DiComo CJ, Gaiddon C, Prives C. 1999. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol 19:1438-1449.
8. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. 2003. TP53 and gastric carcinoma: a review. Hum Mutat 21:258-270.
9. Gasco M, Yulug IG, Crook T 2003. TP53 mutations in familial breast cancer: functional aspects. Hum Mutat 21:301-306.
10. Giglia-Mari G, Sarasin A. 2003. TP53 mutations in human skin cancers. Hum Mutat 21:217-228.
11. Hainaut P, Hollstein M. 2000. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77:81-137.
12. Harris CC. 1993. p53 - at the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980-1981.
13. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253:49-53.
14. Iacopetta B. 2003. TP53 mutation in colorectal cancer. Hum Mutat 21:271-276.
15. Lane DP, Benchimol S. 1990. p53: oncogene or anti-oncogene? Genes and Development 4:1-8.
16. Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M. 2001. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene 20:320-328.
17. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607-614.
18. Parant JM, Lozano G. 2003. Disrupting TP53 in mouse models of human cancers. Hum Mutat 21:321-326.
19. Peller S, Rotter V. 2003 TP53 in hematological cancer: low incidence of mutations with significant clinical relevance. Hum Mutat 21:277-284.
20. Schuijer M, Berns E MJJ. 2003. TP53 and ovarian cancer. Hum Mutat 21:285-291.
21. Soussi T, Dehouche K, Béroud C. 2000. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat 15:105-113.
22. Soussi T, Béroud C. 2001. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233-240.
23. Soussi T, Béroud C. 2003. Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG sites. Hum Mutat 21:192-200.
24. Staib F, Hussain SP, Wang XW, Harris CC. 2003. TP53 and liver carcinogenesis. Hum Mutat 21:201-216.
25. Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M, Blandino G. 2000. Physical and functional interaction between p53 mutants and different isoforms of p73. J Biol Chem 275:29503-29512.
26. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD. 1989. p53 - a frequent target for genetic abnormalities in lung cancer. Science 246:491-494.
27. Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I. 2003. The role of TP53 in cervical carcinogenesis. Hum Mutat 21:307-312.
28. Toyooka S, Tsuda T, Gazdar AF. 2003. The TP53 gene, tobacco exposure and lung cancer. Hum Mutat 21: 229-239.
29. Vähäkangas K. 2003. TP53 mutations in exposed workers. Hum Mutat 21:229-239.
30. Varley JM. 2003. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313-320.
31. Yang A, McKeon F. 2000. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:199-207.